Full text

Turn on search term navigation

© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Aims

We aimed to establish a nomogram for lung cancer using patients' characteristics and potential hematological biomarkers.

Methods

Principle component analysis was used to reduce the dimensions of the data, and each component was transformed into categorical variables based on cutoff values obtained using the X-tile software. Multivariate analysis was used to determine potential prognostic biomarkers. Five components were used in the predictive nomogram. Internal validation of the model was performed by bootstrapping of samples, while external validation was performed on a separate cohort from Shandong Cancer Hospital. The predictive accuracy of the model was measured by concordance index and risk group stratification. Decision curve analysis was performed to evaluate the net benefit of the models.

Results

One hundred patients in the Discovery group and 111 patients in the Validation group were retrospectively analyzed in this study. Forty-seven indexes were sorted into eight subgroups. Five components based on cox regression analysis were enrolled into the predictive nomogram. The nomogram prediction of the probability of 3- and 5-year overall survival was in great concordance with the actual observations. Of interest, the nomogram allowed better risk stratification of patients and better accuracy in predicting patients' survival compared with pathological tumor-node-metastasis staging system.

Conclusion

A nomogram was established for prognosis of lung cancer, which can be used for treatment selection and clinical care management.

Details

Title
A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators
Author
Cheng, Bo 1 ; Wang, Cong 2 ; Zou, Bing 1 ; Huang, Di 2 ; Yu, Jinming 1   VIAFID ORCID Logo  ; Cheng, Yufeng 2 ; Xue Meng 1   VIAFID ORCID Logo 

 Department of Radiation Oncology, Cancer Hospital of Shandong Province, Jinan, P. R. China 
 Department of Radiation Oncology, Qilu Hospital, Shandong University, Jinan, P. R. China 
Pages
1430-1440
Section
CLINICAL CANCER RESEARCH
Publication year
2020
Publication date
Feb 2020
Publisher
John Wiley & Sons, Inc.
e-ISSN
20457634
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2353326292
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.